In humans, disruption of the maternally inherited H19ICR results in biallelic IGF2 along with reduced H19 expression and is associated with the developmental disorder, Beckwith–Wiedemann syndrome (BWS) (Jacob et al., 2013). The gene discussed is IGF2; the disease is Beckwith-Wiedemann syndrome.